Kalvista Pharmaceuticals Inc (KALV)
Cost of Revenue
$9.24M
TTM · Period ending: · USD
KALV Cost of Revenue
Latest reported$9.24Mperiod ending
Latest reported$9.24Mperiod ending
KALV TTM Cost of Revenue ($0.00 → $9.24M)
TTM cost of revenue
High-resolution chart · PNG
KALV cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 9,243,000 | |
| 21,158,000 | |
| 17,713,000 | |
| 16,481,000 | |
| 15,891,000 | |
| 25,248,000 | |
| 25,455,000 | |
| 44,544,000 | |
| 63,851,000 | |
| 62,554,000 | |
| 82,410,000 | |
| 81,398,000 | |
| 80,277,000 | |
| 75,539,000 | |
| 55,476,000 | |
| 37,399,000 | |
| 19,213,000 | |
| 11,877,000 | |
| 11,877,000 | |
| 11,877,000 | |
| 11,877,000 | |
| 9,485,000 | |
| 9,485,000 | |
| 9,485,000 | |
| 9,485,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |